Share on StockTwits

AstraZeneca plc (LON: AZN) received a number of ratings updates from brokerages and research firms in the last week:

  • AstraZeneca plc had its “hold” rating reaffirmed by analysts at Jefferies Group. They now have a GBX 4,500 ($74.47) price target on the stock.
  • AstraZeneca plc had its “hold” rating reaffirmed by analysts at Deutsche Bank. They now have a GBX 4,000 ($66.19) price target on the stock.
  • AstraZeneca plc had its “hold” rating reaffirmed by analysts at Beaufort Securities.
  • AstraZeneca plc had its “hold” rating reaffirmed by analysts at Panmure Gordon. They now have a GBX 4,400 ($72.81) price target on the stock.

AstraZeneca plc (LON:AZN) opened at 4418.00 on Monday. AstraZeneca plc has a one year low of GBX 442.867 and a one year high of GBX 5750.00. The stock’s 50-day moving average is GBX 4313. and its 200-day moving average is GBX 4209.45. The company’s market cap is £55.799 billion.

AstraZeneca PLC (LON:AZN) is a global biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.